Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: A clinical-hemodynamic correlation study

Hepatology

Volumn 51, Issue 6, 2010, Pages 2108-2116

  La Mura, Vincenzo ^a   Abraldes, Juan G ^a   Berzigotti, Annalisa ^a   Erice, Eva ^a   Flores Arroyo, Alexandra ^a   García Pagán, Juan Carlos ^a   Bosch, Jaime ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NADOLOL; PROPRANOLOL;

ABDOMINAL PRESSURE; ADULT; ARTICLE; BLEEDING; CALCULATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE FREE SURVIVAL; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART RIGHT ATRIUM PRESSURE; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BLOOD PRESSURE DETERMINATION; FEMALE; HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL PRESSURE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 77952734979     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23612     Document Type: Article

References (35)

1. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. HEPATOLOGY 2004;39:280-282. (Pubitemid 38222164)
2. Bosch J, Garcia-Pagan JC, Berzigotti A, Abraldes JG. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis 2006;26:348-362. (Pubitemid 44632926)
3. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-176.
4. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. HEPATOLOGY 2003;37:902-908. (Pubitemid 36397403)
5. Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell'Era A, Bosch J. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol 2006;101:506-512. (Pubitemid 43340926)
6. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481-488. (Pubitemid 47187350)
7. Ripoll C, Banares R, Rincon D, Catalina MV, Lo IO, Salcedo M, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era. HEPATOLOGY 2005;42:793-801. (Pubitemid 41401116)
8. D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006;131:1611-1624. (Pubitemid 44708947)
9. Albillos A, Banares R, Gonzalez M, Ripoll C, Gonzalez R, Catalina MV, et al. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Am J Gastroenterol 2007;102:1116-1126. (Pubitemid 46698256)
10. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-1022. (Pubitemid 26327605)
11. D'Amico G, Luca A. Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol 1997;11:243-256.
12. Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:576-582.
13. Luca A, Cirera I, Garcia-Pagan JC, Feu F, Pizcueta P, Bosch J, et al. Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis. Gastroenterology 1993;104:222-227. (Pubitemid 23040026)
14. Huonker M, Schumacher YO, Ochs A, Sorichter S, Keul J, Rossle M. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999;44:743-748. (Pubitemid 29195928)
15. Stanley AJ, Redhead DN, Bouchier IA, Hayes PC. Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis. Am J Gastroenterol 1998;93:2463-2468.
16. Stanley AJ, Forrest EH, Redhead DN, Bouchier IA, Hayes PC. Direct measurement of post-prandial portal haemodynamics in cirrhotic patients with a transjugular intrahepatic portosystemic stent-shunt. Eur J Gastroenterol Hepatol 1998;10:393-397.
17. Jalan R, Forrest EH, Redhead DN, Dillon JF, Hayes PC. Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut 1997;40:664-670.
18. Van der LP, Le Moine O, Ghysels M, Ortinez M, Deviere J. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. HEPATOLOGY 1996;23:982-987. (Pubitemid 26137036)
19. Forster J, Delcore R, Payne KM, Siegel EL. The role of transjugular intrahepatic portosystemic shunts in the management of patients with end-stage liver disease. Am J Surg 1994;168:592-596. (Pubitemid 24378524)
20. Urbani L, Catalano G, Cioni R, Petruzzi P, Bindi L, Biancofiore G, et al. Management of massive and persistent ascites and/or hydrothorax after liver transplantation. Transplant Proc 2003;35:1473-1475. (Pubitemid 36765568)
21. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. HEPATOLOGY 2005;41:386-400. (Pubitemid 40165385)
22. Bosch J, Groszmann RJ. Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis. HEPATOLOGY 1984;4:424-429. (Pubitemid 14116642)
23. Bosch J, Mastai R, Kravetz D, Bruix J, Gaya J, Rigau J, et al. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. HEPATOLOGY 1984;4:1200-1205. (Pubitemid 15192273)
24. Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodes J. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients. J Hepatol 1985;1:125-139. (Pubitemid 15038042)
25. La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, Garcia-Pagan JC, et al. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension. J Hepatol 2009;51:279-287.
26. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-852.
27. Casado M, Bosch J, Garcia-Pagan JC, Bru C, Banares R, Bandi JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998;114:1296-1303. (Pubitemid 28243916)
28. Abraldes JG, Gilabert R, Turnes J, Nicolau C, Berzigotti A, Aponte J, et al. Utility of color Doppler ultrasonography predicting tips dysfunction. Am J Gastroenterol 2005;100:2696-2701. (Pubitemid 43919637)
29. Bartko JJ. Measures of agreement: a single procedure. Stat Med 1994;13:737-745.
30. Szklo M, Nieto FJ. Epidemiology - Beyond the Basics. Gaithersburg, MD: Aspen Publishers; 2000.
31. Gluud C, Brok J, Gong Y, Koretz RL. Hepatology may have problems with putative surrogate outcome measures. J Hepatol 2007;46:734-742. (Pubitemid 46420383)
32. Thalheimer U, Bosch J, Burroughs AK. How to prevent varices from bleeding: shades of grey - the case for nonselective beta blockers. Gastroenterology 2007;133:2029-2036. (Pubitemid 350180826)
33. Feu F, Bordas JM, Luca A, Garcia-Pagan JC, Escorsell A, Bosch J, et al. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. HEPATOLOGY 1993;18:1082-1089. (Pubitemid 23320436)
34. Feu F, Bordas JM, Garcia-Pagan JC, Bosch J, Rodes J. Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertension. HEPATOLOGY 1991;13:917-922.
35. Escorsell A, Bordas JM, Castaneda B, Llach J, Garcia-Pagan JC, Rodes J, et al. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. HEPATOLOGY 2000;31:1061-1067. (Pubitemid 30233229)